The Archive · 5 posts
Innovating for better healing! 🩹 Advanced Medical Solutions (AMS) leads in wound care & surgical solutions. A smart investment in health innovation. 📈
AMS delivered higher revenue, margins and adjusted profit, while exceptional costs, weaker cash flow and the takeover shaped the headline figures.
Showing 4 of 5 posts
AMS expects first-half revenue to rise to £115.2 million, while integration progress supports confidence in its full-year EBITDA outlook.
JoshuaJuly 20, 2026
Advanced Medical Solutions reports record 2025 results with 29% revenue growth, strong organic momentum, and a 10% dividend increase. Positive outlook for 2026.
JoshuaMarch 18, 2026
AMS reports 66% revenue growth in H1 2025, maintains full-year guidance, and increases dividend by 10% as Peters Surgical acquisition drives strong performance.
JoshuaSeptember 17, 2025
AMS reports strong H1 2025 revenue of £110m (+62% YoY) and rising EBITDA, driven by surgical growth and successful Peters Surgical/Syntacoll integrations delivering early synergies. Confirms FY outlook.
JoshuaJuly 15, 2025
September 16, 2026